Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
RenovaCare Inc (EM)
RCAR
Healthcare
Biotechnology
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells...
to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (EXPM:RCAR)
New Post
View:
Posts & Comments
Threaded Posts
(10)
•••
oldtimer42
X
Post by
oldtimer42
on Dec 09, 2022 9:39am
Anybody Buying
Anybody buying on speculation at the giveaway price. I got out of this at $8 a few years ago. Surely there is potential for the product if the legal scenario is solved.
(7)
•••
Ferrari328
X
Post by
Ferrari328
on May 31, 2020 1:20pm
Building your position
Now and still is the time to keep building your position, if you feel comfortable.
(7)
•••
Ferrari328
X
Post by
Ferrari328
on May 31, 2020 1:16pm
latest update
RenovaCare Strengthens FDA Program with Leading U.S. Regulatory Group and Significant Investment RCAR | 3 days ago ROSELAND, N.J., May 28, 2020
...more
(7)
•••
Ferrari328
X
Post by
Ferrari328
on Jul 11, 2019 9:46am
Dr.Ben Walthall from J and J join board.
Former Johnson & Johnson Worldwide Director for Advanced Wound Care Joins RenovaCare RCAR | 1 hour ago SCOTTSDALE, Ariz., July 11, 2019 (GLOBE NEWSWIRE) --
...more
(7)
•••
Ferrari328
X
Comment by
Ferrari328
on Jul 10, 2019 1:07pm
RE:RE:Buying
great time to keeping adding to the portfolio for long term.
(0)
•••
Tootall6t9
X
Comment by
Tootall6t9
on Jul 03, 2019 1:28pm
RE:Buying
that's what I think to and when the sec is done investigating rcar will b ready to file for FDA approval avita has already paved a trail and rcar has a better product
(7)
•••
Ferrari328
X
Post by
Ferrari328
on Feb 02, 2019 2:01pm
Buying
RenovaCare Chairman Invests $15.5 Million to Fund SkinGun™ Regulatory Submissions and Clinical Trials. When insider is adding money that a great sign to start build our position. looks good
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
A custom portable drill advancing exploration in Labrador
A clean tech company on the verge of transformational growth plans to uplist to major US exchange
Vertical integration could reshape this scaling beverage brand’s long-term outlook
A transformational year in 2025 and positive outlook for growth in revenue and profitability in 2026
Podcasts